Omeros Corporation (OMER) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Omeros Corporation (OMER) closed at USD 18.43 on 2026-10-14, a change of +131.5 % over the past year, with a market capitalization of USD 1.36B.

Omeros Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Omeros Corporation key figures

Previous close

USD 18.43 (2026-10-14)

1-year change

+131.5 %

Market cap

USD 1.36B

Enterprise value

USD 1.53B

P/E ratio (trailing)

15.53

P/E ratio (forward)

15.28

EPS (trailing)

1.21

EPS (forward)

1.23

PEG ratio

0.81

Price to book

-26.39

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.54

Employees

175

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Omeros Corporation

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Omeros Corporation and compare it with other stocks.